| Literature DB >> 35454381 |
Yujin Kwon1, Boram Lee2, Jai Young Cho2, Ho-Seong Han2, Yoo-Seok Yoon2, Hae Won Lee2, Jun Suh Lee2, Munwhan Kim2, Youngsoo Jo2.
Abstract
Background andEntities:
Keywords: complication; hepatectomy; prognosis; survival
Mesh:
Year: 2022 PMID: 35454381 PMCID: PMC9032568 DOI: 10.3390/medicina58040543
Source DB: PubMed Journal: Medicina (Kaunas) ISSN: 1010-660X Impact factor: 2.948
Preoperative characteristics of laparoscopic liver resection for hepatocellular carcinoma in posterosuperior segments of the liver.
| All Patients | Case-Matched Patients | |||||
|---|---|---|---|---|---|---|
| Characteristics | Group 1 | Group 2 | * Group 1 | * Group 2 | ||
| Age | 54.7 ± 9.4 | 61.6 ± 11.1 | <0.001 | 56.1 ± 9.7 | 58.6 ± 10.3 | 0.202 |
| Gender | 0.029 | 1.000 | ||||
| Male | 27 (62.8) | 161 (79.3) | 25 (73.5) | 73 (71.6) | ||
| Female | 16 (37.2) | 42 (20.7) | 9 (26.5) | 29 (28.4) | ||
| * BMI (kg/m2) |
|
| 0.062 |
|
| 0.151 |
| Tumor size (cm) |
|
| 0.415 |
|
| 0.493 |
| * ICG-R15 |
|
| 0.420 |
|
| 0.479 |
| * AFP (ng/mL) |
|
| 0.930 |
|
| 0.782 |
| Child-Pugh class, | 1.000 | 0.680 | ||||
| A | 41 (95.3) | 191 (94.1) | 33 (97.1) | 96 (94.1) | ||
| B | 2 (4.7) | 12 (5.9) | 1 (2.9) | 6 (5.9) | ||
| C | 0 | 0 | 0 | 0 | ||
| Hepatitis, | 0.022 | 0.465 | ||||
| Hepatitis B | 35 (81.4) | 124 (61.4) | 27 (79.4) | 75 (73.5) | ||
| Hepatitis C | 3 (7.0) | 12 (5.9) | 3 (8.8) | 6 (5.9) | ||
| Both negative | 5 (11.6) | 66 (32.7) | 4 (11.8) | 21 (20.6) | ||
| Prior * RFA, | 4 (9.3) | 14 (6.9) | 0.529 | 3 (8.8) | 9 (8.8) | 0.618 |
| Prior * TACE, | 11 (25.6) | 46 (22.7) | 0.693 | 9 (26.5) | 25 (24.5) | 0.822 |
* Group 1 patients who underwent liver resection before introduction of advanced approach in 2012, group 2 patients who underwent liver resection after introduction of advanced approach in 2012, BMI body mass index, AFP alpha-fetoprotein, ICG-R15indocyanine green clearance rate at 15 min, RFA radiofrequency ablation, TACE transarterial chemo-embolization.
Perioperative outcomes of laparoscopic liver resection for hepatocellular carcinoma in posterosuperior segments of the liver.
| Characteristics | * Group 1 | * Group 2 | |
|---|---|---|---|
| Operation type, | 0.031 | ||
| Tumorectomy | 5 (14.7) | 46 (45.1) | |
| Segmentectomy | 8 (23.5) | 16 (15.7) | |
| Bisegmentectomy | 0 | 3 (2.9) | |
| Left hemihepatectomy | 1 (2.9) | 3 (1.5) | |
| Extended left hemihepatectomy | 0 | 0 | |
| Right anterior sectionectomy | 1 (2.9) | 6 (5.9) | |
| Right posterior sectionectomy | 9 (26.5) | 8 (7.8) | |
| Right hepatectomy | 7 (20.6) | 8 (7.8) | |
| Extended right hepatectomy | 0 | 1 (1.0) | |
| Central bisectionectomy | 1 (2.9) | 1 (1.0) | |
| Combined resection | 0 | 1 (1.0) | |
| Caudate lobectomy | 2 (5.9%) | 5 (4.9) | |
| Extended segmentectomy | 0 | 4 (3.9) | |
| Extended right anterior sectionectomy | 0 | 0 | |
| Extended right posterior sectionectomy | 0 | 1 (0.7) | |
| Type of resection, | 0.017 | ||
| Anatomical | 23 (67.6) | 44 (43.1) | |
| Non-anatomical | 14 (32.6) | 106 (51.5) | |
| Operation time (min) |
|
| 0.002 |
| Pringle method, | 5 (14.7) | 65 (63.7) | <0.001 |
| Open conversion, | 7 (20.6) | 9 (8.8) | 0.475 |
| Blood loss (ml) |
|
| 0.418 |
| Transfusion, | 11 (32.4) | 20 (19.6) | 0.157 |
* Group 1 patients who underwent liver resection before introduction of advanced approach in 2012, group 2 patients who underwent liver resection after introduction of advanced approach in 2012.
Pathologic and postoperative outcomes of laparoscopic liver resection for hepatocellular carcinoma in posterosuperior segments of the liver.
| Characteristics | * Group 1 | * Group 2 | |
|---|---|---|---|
| Resection margin (mm) |
|
| 0.075 |
| Cirrhosis, | 24 (70.6) | 64 (62.7) | 0.535 |
| Satellite nodules, | 3 (8.8) | 2 (2.0) | 0.100 |
| Microvascular invasion, | 13 (39.4) | 43 (42.2) | 0.841 |
| Resection, | 1.000 | ||
| R0 | 33 (97.1) | 98 (96.1) | |
| R1 | 1 (2.9) | 4 (3.9) | |
| Postoperative complication, | 7 (20.6) | 26 (25.5) | 0.649 |
| Type of complication, | 0.103 | ||
| General | 0 | 12 (11.8) | |
| Surgical | 5 (14.7) | 5 (4.9) | |
| Liver-related | 1 (2.9) | 5 (4.9) | |
| Mixed | 1 (2.9) | 4 (3.9) | |
| Clavien-Dindo grade, | 0.583 | ||
| I | 2 (5.9) | 4 (3.9) | |
| II | 0 | 8 (7.8) | |
| IIIa | 4 (11.8) | 10 (9.8) | |
| IIIb | 1 (2.9) | 3 (2.9) | |
| IVa | 0 | 0 | |
| IVb | 0 | 0 | |
| V | 0 | 2 (1.5) | |
| Hospital stay (days) |
| 0.032 | |
| Mortality within 90 days, | 0 | 2 (2.0) | 1.000 |
| Recurrence, | 19 (55.9) | 44 (43.1) | 0.235 |
| Intrahepatic | 0.063 | ||
| Extrahepatic | 19 (55.9) | 32 (31.4) | |
| Both | 1 (2.9) | 6 (5.9) | |
| Management of Recurrence, | 0 | 4 (3.9) | |
| Re-do resection | 0.001 | ||
| TACE | 3 (8.8) | 4 (3.9) | |
| RFA | 3 (8.8) | 27 (26.5) | |
| Medical | 3 (8.8) | 2 (2.0) | |
| Surgery and RFA | 1 (2.9) | 5 (4.9) | |
| TACE and RFA | 1 (2.9) | 0 |
* Group 1 patients who underwent liver resection before introduction of advanced approach in 2012, group 2 patients who underwent liver resection after introduction of advanced approach in 2012.
Figure 1Overall survival: five-year overall survival rate in Group 1 and Group 2.
Figure 2Disease free survival: five-year disease free survival rate in Group 1 and Group 2, case-matched analysis.